Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (12 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Dalacin

As of 02 Nov 2026 10:44 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England noticeMSN/2021/030 Tier 2 · issued 14 Jun 2021 (1967 days ago)
Expected backw/c 6th September 2021 as stated in the latest recorded notice stated date passed — no update recorded (1877 days)window end 12 Sep 2021, derived from “w/c 6th September 2021”
Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register
ScotlandMSAN(2021)30 issued 06 Aug 2021 — NHS Scotland's own notice, matched by name; kept separate from England

Presentations, as stated in the latest recorded notice

Each line is re-expressed from MSN/2021/030 (14 Jun 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.

PresentationStatus, as statedExpected back, as statedStated in
Dalacin® (clindamycin) 2% vaginal creamaffected product · inferred from phrasingOut of stock, as statedw/c 6th September 2021precision: a month · window end 12 Sep 2021, derived from “w/c 6th September 2021”notice of 14 Jun 2021
Alternative topical preparationsclass-level statement by the source, not a named product · inferred from phrasingStated as available— not stated for this linenotice of 14 Jun 2021

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

The latest recorded notice names no alternative as remaining available.

Identifiers — Dalacin

Also known as
Dalacin 2% cream
BNF chemical
Clindamycin phosphate 0702020E0 — matched on a brand name
Class
Vaginal and vulval infections · Treatment of vaginal and vulval conditions · Obstetrics, Gynaecology and Urinary-Tract Disorders
SNOMED codes
358511000001100
Suppliers named in the NHSBSA dataset
Pfizer Ltd (from the dataset, not from the notices)

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 14 Jun 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

IssuedNoticeKindTierReference
14 Jun 2021Medicine Supply Notification: Dalacin® (clindamycin) 2% vaginal cream - UpdatedSupply notificationTier 2MSN/2021/030

Also recorded under

Bracketed names seen in this medicine's notice titles: clindamycin. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
23 Jul 2024
Sources
Latest notice post ↗https://cpe.org.uk/our-news/medicine-supply-notification-dalacin-clindamycin-2-vaginal-cream · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.